Nature’s Breakthrough: BPD-9 Targets Tuberculosis with Revolutionary Effectiveness
Recent advancements in medical research have unveiled a promising new compound called BPD-9, derived from the natural antimicrobial agent sanguinarine. This semi-synthetic compound has shown remarkable effectiveness against Mycobacterium tuberculosis (M. tuberculosis), including strains resistant to conventional treatments. This discovery could pave the way for more effective tuberculosis (TB) therapies, a pressing public health concern… Read More »
